BSE filing, BSE: 531207. Summary written from the filing by ALFA Finder's alert engine.
More from Cresanto Global Ltd
All →Cresanto Global Annual General Meeting
Cresanto Global Limited conducted its 34th Annual General Meeting on August 31, 2026. Shareholders approved the adoption of audited financial statements and a registered office relocation.
Cresanto Global Q1 FY27 Results: Net Loss of ₹0.1 Cr, Loss Widens
Cresanto Global Ltd reported a net loss of ₹0.1 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.1 Cr
Cresanto Global Board Meeting Date
Cresanto Global Limited has scheduled a board meeting for August 13, 2026. The board will consider unaudited financial results for the quarter ended June 30, 2026.
Cresanto Global Annual General Meeting
Cresanto Global Limited has issued a notice for its Annual General Meeting scheduled for August 31, 2026, to transact various business resolutions and related party transactions.
- Value
- ₹60.00 Cr
Cresanto Global Annual Report
Cresanto Global Limited has published its 34th Annual Report for the financial year 2025-2026, convening the AGM for August 31, 2026.
Cresanto Global Annual General Meeting
Cresanto Global Limited has issued a notice for its 34th Annual General Meeting, scheduled for August 31, 2026, to conduct ordinary and special business.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.